These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5622849)

  • 21. [Changes of the coefficient of peripheral utilization of glucose after venous administration, in hypercholesteremic subjects, after treatment with an antidyslipidemic agent].
    Pasini P
    G Gerontol; 1969 Aug; 17(8):808-16. PubMed ID: 5371744
    [No Abstract]   [Full Text] [Related]  

  • 22. Enzyme activities in the germinal layer of normal and psoriatic human skin.
    Hammar H; Thyresson N; Brolin SE
    Acta Derm Venereol; 1968; 48(3):175-80. PubMed ID: 4176737
    [No Abstract]   [Full Text] [Related]  

  • 23. [Activity of glucose-6-phosphate dehydrogenase in erythrocytes in patients with atopic asthma and allergic rhinitis].
    Tyran W; Wrzyszcz M
    Pneumonol Alergol Pol; 1992; 60(7-8):26-31. PubMed ID: 1493515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucose-6-phosphate dehydrogenase in the skin cycle].
    Crovato F
    G Ital Dermatol Minerva Dermatol; 1971 Jul; 46(7):310-1. PubMed ID: 5110052
    [No Abstract]   [Full Text] [Related]  

  • 25. Iron metabolism in skin disease.
    Marks J; Shuster S
    Arch Dermatol; 1968 Nov; 98(5):469-75. PubMed ID: 5303116
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental studies of the mechanism of action of chrysarobin and dithranol in psoriasis (evidence for a cytostatic effect on the epidermis)].
    Krebs A; Schaltegger H
    Dermatologica; 1965; 131(1):1-27. PubMed ID: 4284321
    [No Abstract]   [Full Text] [Related]  

  • 27. [Steroids and skin. IX. On the metabolism of 7 - 3 H-DHEA sulfate in psoriasis].
    Oertel GW; Hoffmann G; Morsches B; Holzmann H
    Steroidologia; 1971; 2(3):175-84. PubMed ID: 4259648
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glucosephosphate dehydrogenase (G-6 PD) in the blood of patients with psoriasis].
    Růzicka J; Novotná V; Melichar M
    Cesk Dermatol; 1967 Oct; 42(5):318-26. PubMed ID: 6080251
    [No Abstract]   [Full Text] [Related]  

  • 29. [The influence of coal tar and y perit ointments on the oxidative metabolism of glucose in the skin of psoriatics].
    Růzicka J; Novotná-Kaspárková V; Burda V
    Arch Klin Exp Dermatol; 1969; 234(2):175-81. PubMed ID: 5820630
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous measurement of pentose phosphate pathway activity in erythrocytes. An ionization chamber method.
    Davidson WD; Tanaka KR
    J Lab Clin Med; 1969 Jan; 73(1):173-80. PubMed ID: 5762160
    [No Abstract]   [Full Text] [Related]  

  • 31. [Psoriasis: A general disease? Can psoriasis be explained biochemically?].
    Goerz G
    Hautarzt; 1977 Apr; 28(4):173-7. PubMed ID: 194871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glycolysis and the activity of some enzymes in erythrocytes from patients with Marchiafava-Micheli disease].
    Cherniak NB; Asriian IS
    Vopr Med Khim; 1968; 14(1):54-7. PubMed ID: 5683371
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histochemical changes in the skin in psoriasis patients during treatment with vitamin A].
    Vedrova IN; Sapelkina IM
    Vestn Dermatol Venerol; 1969 Feb; 43(2):30-1. PubMed ID: 5376556
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic changes at the margin of the spreading psoriatic lesion.
    van de Kerkhof PC; van Rennes H; de Grood R; Bauer FW; Mier PD
    Br J Dermatol; 1983 Jun; 108(6):647-52. PubMed ID: 6860560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis.
    Drewa G; Krzyzyńska-Malinowska E; Woźniak A; Protas-Drozd F; Mila-Kierzenkowska C; Rozwodowska M; Kowaliszyn B; Czajkowski R
    Med Sci Monit; 2002 Aug; 8(8):BR338-43. PubMed ID: 12165738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro effect of carbon monoxide and lead on glucose-6-phosphate dehydrogenase activity in human erythrocytes].
    Rausa G
    Arcisp S Anna Ferrara; 1968; 21(5):581-90. PubMed ID: 5734733
    [No Abstract]   [Full Text] [Related]  

  • 37. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis.
    Henno A; Blacher S; Lambert C; Colige A; Seidel L; Noël A; Lapière C; de la Brassinne M; Nusgens BV
    Br J Dermatol; 2009 Mar; 160(3):581-90. PubMed ID: 18945297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histochemical characteristics of skin dehydrogenase activity in psoriasis].
    Leĭbman IG
    Arkh Patol; 1970; 32(1):76-81. PubMed ID: 4392825
    [No Abstract]   [Full Text] [Related]  

  • 39. Histopathology and histochemistry of psoriasis. I. The active lesion and clinically normal skin.
    Gordon M; Johnson WC
    Arch Dermatol; 1967 Apr; 95(4):402-7. PubMed ID: 6023045
    [No Abstract]   [Full Text] [Related]  

  • 40. [Glucose utilization and activity of glucose-6-phosphate dehydrogenase, isocitrate dehydrogenase and malate dehydrogenase in rat erythrocytes after treatment with tuberculostatic agents].
    Storozhuk PG; Skliar VA; Korochanskaia SP; Gontmakher IuV
    Vopr Med Khim; 1986; 32(5):32-5. PubMed ID: 3776114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.